Related Experiment Video
Updated: Aug 6, 2026
06:32
Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation
Published on: July 14, 2023
Chatbot Remote Monitoring System in Patients with Schizophrenia: A Pilot Study of User Experience
Consortium Psychiatricum
|July 17, 2026
Summary
Patients with schizophrenia spectrum disorders (SSDs) found chatbot-based remote monitoring acceptable for tracking remission. Improvements like personalized reminders could enhance adherence to digital mental health tools.
Area of Science:
- Digital health
- Psychiatry
- User experience research
Background:
- Remote monitoring offers potential for early relapse detection in schizophrenia spectrum disorders (SSDs).
- Validated digital tools for monitoring SSD remission are lacking in Russia.
- Assessing user experience is crucial for patient adherence to self-monitoring tools.
Purpose of the Study:
- To evaluate the user experience of a chatbot for remote monitoring of remission in patients with SSDs.
Main Methods:
- A 9-day study involved 15 patients with SSDs using a chatbot for daily symptom self-assessment (morning) and quality of life/side effect monitoring (evening).
- Morning sessions included PANSS, CDSS, SSQ, and MGL-4 items; evening sessions used Q-LES-Q-SF and UKU-SERS-Pat.
- Post-study, participants completed a 21-item questionnaire on their technology interaction experience.
Main Results:
- 80% of participants completed over half of the diary sessions.
- High satisfaction was reported with the chatbot's functionality and overall technology acceptability.
- Key limitations identified were the number of questions and lack of personalized notifications.
Conclusions:
- Patients with SSDs showed a positive response to using chatbots for remote remission monitoring.
- Future iterations should streamline interactions and incorporate personalized features like medication reminders and visual symptom tracking.